
GOSS
Gossamer Bio Inc.
$3.16
+$0.11(+3.61%)
81
Overall
--
Value
81
Tech
--
Quality
Market Cap
$693.51M
Volume
4.35M
52W Range
$0.66 - $3.60
Target Price
$9.13
Order:
Income Statement
Metric | Trend | Chart | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||
Total Revenue | -- | -- | -- | -- | -- | $114.7M | ||
Total Revenue | -- | -- | -- | -- | -- | $114.7M | ||
GROSS PROFIT | ||||||||
Gross Profit | -- | -- | -- | -- | -- | $114.7M | ||
OPERATING EXPENSES | ||||||||
Operating Expenses | $186.1M | $234.0M | $216.1M | $218.6M | $183.8M | $174.6M | ||
Research & Development | $147.0M | $184.2M | $170.3M | $170.9M | $135.3M | $138.5M | ||
Research Expense | $147.0M | $184.2M | $170.3M | $170.9M | $135.3M | $138.5M | ||
Selling, General & Administrative | $39.1M | $49.7M | $45.8M | $47.6M | $38.5M | $36.1M | ||
General & Administrative Expenses | $39.1M | $49.7M | $45.8M | $47.6M | $38.5M | $36.1M | ||
Salaries & Wages | -- | -- | -- | $42.6M | $28.5M | $20.6M | ||
Depreciation & Amortization | $900.0K | $1.4M | $1.7M | $1.8M | $1.6M | $800.0K | ||
Depreciation & Amortization | $900.0K | $1.4M | $1.7M | $1.8M | $1.6M | $800.0K | ||
Other Operating Expenses | $-2.3M | $-2.3M | $-2.5M | $-3.0M | $-3.1M | $-2.3M | ||
OPERATING INCOME | ||||||||
Operating income | $-186.1M | $-234.0M | $-216.1M | $-218.6M | $-183.8M | $-59.9M | ||
EBITDA | $-177.4M | $-226.4M | $-209.4M | $-209.9M | $-174.1M | $-50.4M | ||
NON-OPERATING ITEMS | ||||||||
Interest Expense (Non-Operating) | $1.9M | $12.7M | $19.4M | $13.9M | $13.5M | -- | ||
Intinc | -- | -- | -- | $1.6M | $2.0M | $1.8M | ||
Net Non-Operating Interest Income/Expense | $-1.9M | $-12.7M | $-19.4M | $12.3M | $2.0M | $1.8M | ||
Other Income/Expense | $-7.8M | $-3.3M | $-1.6M | $1.4M | $-15.5M | $-14.0M | ||
Other Special Charges | $7.8M | $3.3M | $1.6M | $1.5M | $15.5M | $14.0M | ||
PRE-TAX INCOME | ||||||||
EBIT | $-178.4M | $-230.7M | $-214.6M | $-215.5M | $-179.8M | $-55.6M | ||
Pre-Tax Income | $-180.3M | $-243.4M | $-234.0M | $-229.4M | $-179.8M | $-55.6M | ||
INCOME TAX | ||||||||
Tax Provision | -- | -- | -- | -- | -- | $893.0K | ||
NET INCOME | ||||||||
Net Income | $-180.3M | $-243.4M | $-234.0M | $-229.4M | $-179.8M | $-56.5M | ||
Net Income (Continuing Operations) | $-180.3M | $-243.4M | $-234.0M | $-229.4M | $-179.8M | $-56.5M | ||
Net Income (Discontinued Operations) | $-180.3M | $-243.4M | $-234.0M | $-229.4M | $-179.8M | $-56.5M | ||
Net Income (Common Stockholders) | $-180.3M | $-243.4M | $-234.0M | $-229.4M | $-179.8M | $-56.5M | ||
Normalized Income | -- | -- | -- | -- | -- | $-55.1M | ||
TOTALS | ||||||||
Total Expenses | $186.1M | $234.0M | $216.1M | $218.6M | $183.8M | $174.6M | ||
SHARE & EPS DATA | ||||||||
Average Shares Outstanding | $54.7M | $68.5M | $74.8M | $84.6M | $152.6M | $226.2M | ||
Average Shares Outstanding (Diluted) | $54.7M | $68.5M | $74.8M | $84.6M | $152.6M | $226.2M | ||
Shares Outstanding | $66.3M | $75.5M | $76.5M | $95.0M | $225.6M | $227.2M | ||
Basic EPS | $-3.29 | $-3.55 | $-3.13 | $-2.71 | $-1.18 | $-0.25 | ||
Basic EPS (Continuing Operations) | $-3.29 | $-3.55 | $-3.13 | $-2.71 | $-1.18 | $-0.25 | ||
Diluted EPS | $-3.29 | $-3.55 | $-3.13 | $-2.71 | $-1.18 | $-0.25 | ||
Diluted EPS (Continuing Operations) | -- | -- | $-3.13 | $-2.71 | $-1.18 | $-0.25 | ||
OTHER METRICS | ||||||||
Other Gand A | $39.1M | $49.7M | $45.8M | $47.6M | $38.5M | $36.1M | ||
Rent And Landing Fees | $3.1M | -- | -- | -- | -- | -- |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | GOSS | $3.16 | +3.6% | 4.35M |
3 | ||||
4 | ||||
5 | ||||
6 |